Sun Life to look at effectiveness of pharmacogenetics on plan members
Source: Benefits Canada | Author: Jan Lee | August 25, 2017
From the article:
Sun Life Financial will be offering plan members on short- and long-term disability leave for depression or anxiety the chance to take part in a study on the impact of pharmacogenetic testing.
The insurer is participating in a study that examines the effectiveness of the technology in partnership with the Centre for Addiction and Mental Health and personalized medicine provider Assurex Health Inc.
